Early identification of individuals with pre-symptomatic type 1 diabetes (T1D) has never been more important. As awareness grows, more people are actively seeking trusted, professional clinical sites that offer screening programs or monitoring for those who have tested positive for islet autoantibodies (IAb+).
INNODIA is responding to this need with the Early T1D Navigator—a digital tool designed to help individuals easily find and connect with clinical sites offering these critical programs.
Whether or not you are a member of our Network, INNODIA aims to be the go-to hub for centers conducting screening programs and for people seeking opportunities to get screened or monitored in Europe.
• If your site is already conducting IAb detection or monitoring individuals who are positive for IAb in Europe outside the INNODIA Detect Program, and you would like to expand your reach to include more participants, fill the form and add your site to the INNODIA Early T1D Navigator:
• If you are an INNODIA Member and your site is participating to the DETECT Program or will be soon activated, we will reach out.